HomeSNNAQ • OTCMKTS
add
Sienna Biopharmaceuticals Inc
Previous close
$0.00
Market cap
30.00 USD
Avg Volume
206.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2018info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 70.20M | 54.00% |
Net income | -73.47M | -45.36% |
Net profit margin | — | — |
Earnings per share | -3.59 | 30.83% |
EBITDA | -70.04M | -54.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2018info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.53M | -34.84% |
Total assets | 107.31M | -21.59% |
Total liabilities | 80.72M | 76.84% |
Total equity | 26.58M | — |
Shares outstanding | 30.07M | — |
Price to book | 0.00 | — |
Return on assets | -35.94% | — |
Return on capital | -59.33% | — |
Cash Flow
Net change in cash
| (USD) | 2018info | Y/Y change |
|---|---|---|
Net income | -73.47M | -45.36% |
Cash from operations | -61.69M | -50.43% |
Cash from investing | -39.00K | 85.34% |
Cash from financing | 35.96M | -66.32% |
Net change in cash | -25.94M | -139.64% |
Free cash flow | -21.70M | 26.08% |
About
Founded
2010
Headquarters
Website
Employees
13
